Drug factory · FDA FEI 3003699242
Lacsa Pty Ltd
72 Ballantrae Road, Merebank, Durban, South Africa
Problems found, fixed voluntarily at FDA's last inspection, Jul 24, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2011: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Lactulose | Makes it | Bio-Pharm, Inc. | 59741-249 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 24, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 12, 2018 | No problems found | Drug Quality Assurance | — |
| Nov 6, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 17, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.